EP2707003
Kristölluð sölt af 84S,4AS,5AR,12AS)-4-dímetýlamínó-3,10,12,12A-tetrahýdroxý-7-[(metoxý(metýl)amínó)-metýl]-1,11-díoxó-1,4,4A,5,5A,6,11,12A-oktahýdró-naftasen-2-karboxýlsýruamíð og aðferðir við að nota þau
:
EP einkaleyfi í gildi á Íslandi:
14.5.2012:
1.5.2019:
12782600.6
:
16.7.2019:
15.8.2019
:
13.5.2032:
13.5.2025:
31.5.2025
:
CRYSTALLINE SALTS OF (4S,4AS,5AR,12AS)-4-DIMETHYLAMINO-3,10,12,12A-TETRAHYDROXY-7-[(METHOXY(METHYL)AMINO)-METHYL]-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-NAPHTHACENE-2-CARBOXYLIC ACID AMIDE AND METHODS OF USING THE SAME
14.5.2012
1.5.2019
16.7.2019
15.8.2019
13.5.2025
:
Paratek Pharmaceuticals, Inc.:
75 Park Plaza, 02116, Boston, US
:
Allergan Pharmaceuticals International Limited:
Clonshaugh Industrial Estate, Coolock, 17, Dublin, IE
:
COULTER, Catherine:
BallymenaCo Antrim, IE
:
JOHNSTON, Sean, M.:
DoylestownPA, US
:
SEYEDI, Farzaneh:
MansfieldMA, US
:
G.H. Sigurgeirsson ehf.:
Borgartúni 26, 105, Reykjavík,
:
201161485179 P:
12.5.2011:
US
:
US2012037838:
14.5.2012
:
A61K 31/65, C07C 237/26
: 8
: 24.7.2019
: 13.5.2020
: G. H. Sigurgeirsson
: 9
: 20.4.2020
: 13.5.2021
: Sigurjónsson & Thor ehf.
: 10
: 20.4.2021
: 13.5.2022
: Sigurjónsson & Thor ehf.
: 11
: 3.5.2022
: 13.5.2023
: Patice ehf.
: 12
: 31.10.2023
: 13.5.2024
: Árnason Faktor ehf.
: 13
: 2.5.2024
: 13.5.2025
: Árnason Faktor ehf.